Press release
Clinoptima Secures Fully Funded Global Partnership to Advance Next-Generation RiPPs Therapeutics
Clinoptima Bio Research Announces Fully Funded Strategic Partnership With Global Pharmaceutical Leader to Advance Next-Generation RiPPs-Based Therapeutics
Sao Paulo, Brazil - Clinoptima Bio Research (https://clinoptima.io/), a leader in AI-enhanced biomedical discovery, today announced a major strategic partnership with Bayer Global (https://www.bayer.com/ [https://www.bayer.com/en/]), one of the world's top pharmaceutical innovators, to advance a new generation of Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs) for precision therapeutics.
Under the agreement, Bayer Global will provide full programme funding, covering research, development, platform integration, laboratory expansion, and all associated pipeline milestones.
The collaboration centers on Project FUSION, a multi-year discovery and translational research initiative designed to:
*
Generate novel RiPP scaffolds using AI-driven modelling to optimize bioactivity, stability, and selectivity
*
Engineer post-translational modification pathways including lanthionine formation, heterocycle installation, and macrocyclization
*
Develop hybrid RiPP-mRNA strategies, enabling mRNA-encoded expression of engineered RiPP precursors in vivo
*
Screen preclinical candidates via Clinoptima's predictive simulation environment for binding affinity, mechanism of action, and toxicity
*
Advance lead RiPP candidates targeting oncology, antimicrobial resistance, and inflammatory disorders
The first wave of preclinical candidates is expected in 2027, with IND-enabling studies anticipated from 2028 onward.
Leadership Commentary
" Fully funded partnerships of this scale are rare in early-stage peptide innovation, " said Dr. Joao Da Silva, CEO of Clinoptima Bio Research. "Bayer's commitment not only validates the strength of our AI-driven RiPPs platform but also accelerates our ability to move discoveries into the clinic. "
A senior representative from Bayer noted: " Clinoptima's computational and synthetic biology capabilities position them at the forefront of next-generation peptide engineering. Our funding and global infrastructure will allow this partnership to translate promising RiPPs science into meaningful therapeutic breakthroughs. "
About the Agreement
*
Bayer will provide full funding for research, platform development, peptide synthesis, and preclinical advancement.
*
Joint expenditures support peptide synthesis, mRNA-expression studies, and expansion of Clinoptima's AI cluster.
*
Clinoptima will lead AI modelling, RiPP design, pathway engineering, and early discovery.
*
Bayer will manage scale-up, clinical development, regulatory strategy, and commercialization.
*
Programme milestones include AI platform integration in 2026, candidate selection and IND preparation in 2027.
Media Contact
Contact Person: William Smith
Email: Send Email [http://www.universalpressrelease.com/?pr=clinoptima-secures-fully-funded-global-partnership-to-advance-nextgeneration-ripps-therapeutics]
Address:15 Nutley Rd, Dublin 4
City: Dublin D04 V2P8
Country: Ireland
Website: https://clinoptima.io/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinoptima Secures Fully Funded Global Partnership to Advance Next-Generation RiPPs Therapeutics here
News-ID: 4477455 • Views: …
More Releases from Getnews
Brian Properties Assumes Management of Industrial Property in Franklin Park
Brian Properties has assumed property management responsibilities for a 35,900-square-foot industrial warehouse/flex property in Franklin Park, Illinois, on behalf of a long-time client transitioning from self-management.
Brian Properties, Inc. [https://www.brianproperties.com/?utm_campaign=41632609-%5BPress%20Release%5D%20Assumes%20Management%20of%20Industrial%20Property%20in%20Franklin%20Park&utm_source=PR_Marketing] has assumed management responsibilities for a 35,900-square-foot industrial warehouse/flex property located at 9120-9138 Medill Avenue in Franklin Park, Illinois. The engagement reflects a continued relationship with a long-time client and a transition from self-management to professional property oversight.
The multi-tenant property consists…
Persefoni Yacht Named Among the Greek Islands' Most Celebrated Superyachts as Me …
As the Mediterranean superyacht season prepares to open across Greece's extraordinary island groups, one vessel is drawing particular attention from the global yachting community: the Persefoni yacht [https://persefoniyacht.com/], a 53.8-metre Italian motor yacht that has become one of the Aegean's most recognised and admired superyachts. Built by the prestigious Mariotti Yachts shipyard in Genoa in 2012 and comprehensively refitted in 2023, Persefoni is managed by Emperio Yachting Alliance [https://emperioyachting.com/], a…
From Wool Sneakers to GPU Racks: The Allbirds AI Pivot and Retail Sentiment
Image: https://www.globalnewslines.com/uploads/2026/04/1776345533.jpg
Cross-platform sentiment split, a Polymarket earnings probability of 0.05% and zero Twitter mentions leave thin evidence of durable retail conviction behind BIRD's move.
BERLIN - April 17, 2026 - Sentiment data from the Adanos Market Sentiment API shows that the 582% single-day rally in Allbirds (NASDAQ: BIRD) on April 15, triggered by the company's rebrand to NewBird AI and a pivot into GPU-as-a-Service, sits on a thin social base: zero…
DJ Mahmut Gorgen to release new projects and expand global reach
Image: https://www.globalnewslines.com/uploads/2026/04/1776423506.jpg
Turkish DJ and producer Mahmut Gorgen announces upcoming music releases and international expansion plans, continuing his work in electronic music.
Turkish DJ and producer Mahmut Gorgen has announced plans to release new music projects and expand his international presence in the electronic music industry.
Gorgen has developed a sound that incorporates rhythm-focused arrangements and contemporary electronic influences. His work explores multiple directions within dance music, including deep house, afro house, melodic…
